Combining BMSCs with miR-181a Shows Synergistic Effects in MS Model
Researchers explore a combination approach using bone marrow stem cells and miR-181a to enhance immunomodulatory effects in a preclinical model of multiple sclerosis.
Day: October 23, 2025